We represented NextGxDx, a genetic testing IT company, in securing $1.5 million. Numerous investors contributed to the capital raise. This raise is in addition to the $5 million raised last year to fund their entrance into the hospital market.
NextGxDx is a healthcare IT company dedicated to improving the cost and clinical integration of genetic testing for the medical community. GeneConnect, NextGxDx’s main product, is a genetic test utilization management solution that allows hospitals to build a formulary that can improve workflow efficiency and drive down the costs associated with genetic testing.